MBNL1-AS1 has been elucidated to be downregulated in non-small cell lung cancer, whose upregulation inhibits proliferation, invasion, migration, drug resistance, and sphere formation of cancer cells [25]. Here, MBNL1 is linked to non-small cell lung carcinoma.